Loading insider details...
Beta
Latest Form 4 (May 5, 2026): Grant/Award of 152,783 KTTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 152,783 | n/a |
| Dec 1, 2025 | Pasithea Therapeutics Corp. (KTTA) | Purchase | 133,333 | $100.0K |
| Oct 27, 2025 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 242,913 | n/a |
| Jun 20, 2025 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 48,198 | n/a |
| Jun 18, 2025 | BioAtla, Inc. (BCAB) | Grant/Award | 23,500 | n/a |
| Feb 21, 2025 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 65,000 | n/a |
| Jun 14, 2024 | BioAtla, Inc. (BCAB) | Grant/Award | 16,500 | n/a |
| Mar 2, 2024 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 7,500 | n/a |
| Dec 20, 2023 | BioAtla, Inc. (BCAB) | Purchase | 20,000 | $41.0K |
| Sep 6, 2023 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 15,000 | n/a |